About: http://webisa.webdatacommons.org/374951793

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	BioCryst has retained all of its development and commercialization rights to peramivir worldwide except in Japan, Taiwan, and South Korea.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com